Inovio Pharma (INO) Tops Q2 EPS by 2c, misses on revenue
Tweet
Share
E-mailGet Alerts INO Hot Sheet
Price: $1.10 +0.92%
Financial Fact:
Research and development: 26.98M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Research and development: 26.98M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Inovio Pharma (NASDAQ: INO) reported Q2 EPS of ($0.13), $0.02 better than the analyst estimate of ($0.15). Revenue for the quarter came in at $230 thousand versus the consensus estimate of $262.5 thousand.
For earnings history and earnings-related data on Inovio Pharma (INO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Is Treasury selloff a major issue for stock market bulls?
- Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
- Femasys Inc. (FEMY) Misses Q2 EPS by 20c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
